Archer Insights named NetSuite Alliance Partner Spotlight Award winner for the 5th consecutive year

Archer Insights has been named a NetSuite Alliance Partner Industry Spotlight Award winner for the 5th consecutive year, with 2026 recognition in Biotech/Biopharma and Medical Devices and Equipment.

CHESTER SPRINGS, PENNSYLVANIA

Chester Springs, Pennsylvania / May 2026

Archer Insights, LLC has been named a NetSuite Alliance Partner Industry Spotlight Award winner for the 5th consecutive year, receiving recognition in 2 categories at the 2026 award cycle: Biotech/Biopharma, continuing a streak that runs from 2022 through 2026, and Medical Devices and Equipment, a category added this year reflecting the firm's expanding work across the medical technology sector. The Spotlight Award is issued annually by Oracle NetSuite to recognize alliance partners that demonstrate exceptional depth and client outcomes within a specific industry vertical.

NetSuite Alliance Partner Industry Spotlight Winner 2022 to 2026, Biotech/Biopharma

NetSuite Alliance Partner Industry Spotlight Winner 2026, Medical Devices and Equipment

Consistent recognition across 5 consecutive years in Biotech/Biopharma positions Archer Insights as one of a small number of NetSuite partners with documented, sustained expertise in regulated life sciences. The addition of Medical Devices and Equipment in 2026 reflects the firm's work supporting manufacturers, combination product developers, and distributors operating under FDA quality system regulations and serialization requirements that standard ERP configurations do not address out of the box.

The work behind both recognitions reflects a deliberate approach to what regulated industries actually need from an ERP implementation. The majority of Archer Insights' clients are publicly traded, and every engagement the firm delivers is built SOX-compliant from the ground up. Segregation of duties, approval hierarchies, and audit-ready financial controls are configured into the system before go-live, not added later in response to an audit finding or a comment from an external auditor. For a biotech company operating under Section 302 and 404 requirements or preparing for an IPO, this structural difference shapes the entire downstream compliance posture of the organization.

Beyond the implementation methodology, Archer Insights has built a library of more than 11 proprietary NetSuite modules that address recurring requirements across life sciences and healthcare. These include an electronic quality management system, accruals automation, wholesale drug licensing, contract lifecycle management, vendor onboarding, OCR invoice capture, and banking integrations. In medical devices, where lot traceability, complaint handling, and CAPA documentation sit alongside standard financial operations, the ability to deploy validated, pre-built solutions significantly reduces both implementation risk and time to value. Clients are not commissioning custom development for problems the firm has already solved across dozens of prior engagements.

Five years in the same category is not an accident, and winning a second category this year reflects the same discipline. We go deep on a small number of verticals, we build solutions that solve the problems we see repeatedly, and we make sure every implementation is ready for audit from day one. That is the work Oracle NetSuite is recognizing.

Nitin Khanna, Founder and CEO, Archer Insights

For prospective clients evaluating NetSuite implementation partners, the Spotlight Award provides an external, category-specific signal of capability that sits outside Archer Insights' own marketing. It is issued by Oracle NetSuite based on client outcomes, not self-nomination. Combined with the firm's inclusion on the Inc. 5000 list of fastest growing private companies and its 2026 Gold Stevie Award for Achievement in Science or Technology, the 2026 Spotlight recognitions form part of a consistent pattern of third party validation across a multi year period.

Existing clients should expect no change in service. Prospective clients in biotech, biopharma, CDMO, specialty pharmacy, medical device, and multi site healthcare organizations who want to learn more about Archer Insights' SOX-compliant implementation approach or pre-built module library can reach the firm through the contact information below.

Recognition Details

DetailValue
Issued byOracle NetSuite
CategoriesBiotech/Biopharma, Medical Devices and Equipment
Consecutive years5 (2022 to 2026)
RecipientArcher Insights, LLC

About Archer Insights

Archer Insights, LLC is a NetSuite Alliance Partner serving life sciences and healthcare organizations. The firm operates 4 service lines: new NetSuite implementations, enhancement services, proprietary software modules, and managed services. Archer Insights has been recognized as a NetSuite Alliance Partner Spotlight Award winner for 5 consecutive years from 2022 through 2026, has been named to the Inc. 5000 list of fastest growing private companies in the United States, and received the Gold Stevie Award for Achievement in Science or Technology at the 2026 American Business Awards. The firm is headquartered in Chester Springs, Pennsylvania, and serves clients across biotech, biopharma, CDMOs, specialty pharmacy, compounding pharmacy, medical device, and multi site healthcare operators.